Urogen Pharma Ltd (URGN)

Stock-Based Compensation

$5.33M

Quarterly · Period ending: · USD

URGN logo

URGN Stock-Based Compensation

Latest reported$5.33M
URGN Quarterly Stock-Based Comp ($91.00K → $5.33M)
High-resolution chart · PNG

URGN stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
5,331,000
4,627,000
3,130,000
3,027,000
2,733,000
3,069,000
3,303,000
3,489,000
3,560,000
2,756,000
2,611,000
2,224,000
2,222,000
2,286,000
2,368,000
0
2,823,000
2,949,000
5,357,000
5,515,000
6,046,000
6,195,000
6,526,000
6,763,000
7,119,000
7,617,000
8,065,000
7,243,000
7,212,000
7,447,000
8,877,000
9,515,000
7,709,000
4,541,000
2,269,000
2,158,000
1,576,000
297,000
581,000
513,000
433,000
440,000
189,000
62,000
91,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.